Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, Kirsten Grønbæk

Research output: Contribution to journalLetterpeer-review

9 Citations (SciVal)
Original languageEnglish
Pages (from-to)e541-e543
Issue number11
Publication statusPublished - 2018

Subject classification (UKÄ)

  • Cancer and Oncology

Cite this